High Enroll eliminates patient recruitment barriers that compromise the quality, number, and timeliness of clinical research studies.
High Enroll has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in August 2022.
High Enroll is headquartered in Cincinnati, United States.
High Enroll eliminates patient recruitment barriers that compromise the quality, number, and timeliness of clinical research studies.
High Enroll is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"High Enroll — Funding & Investors." VCBacked, August 11, 2022, https://www.vcbacked.co/company/high-enroll. Accessed August 14, 2026.
VCBacked. (2022). High Enroll — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/high-enroll
{{cite web |title=High Enroll — Funding & Investors |url=https://www.vcbacked.co/company/high-enroll |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated